Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Sell · Filed 06/03

Trade details

Type: Insider sale
Amount: $338,879.21
Shares · price: 13,253 sh · $25.57 a share
Held after: 1,600 sh
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Trade date: 26/06/01
Filed: 26/06/03
Days to filing: 2 days

Sold 89.2% of holdings

Share of holding sold: 89.2%

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 05/02~07/01

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$251.1K
9,705 sh
$251.1K
Filed 09/04
Traded 09/04
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$42.2K
1,600 sh
$42.2K
Filed 06/03
Traded 06/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$393.3K
15,000 sh
$393.3K
Filed 05/18
Traded 05/14

Harold Bernstein, CMO — sold $338.9K of Maze Therapeutics MAZE · 89.2% of holdings · 10b5-1 plan | Whalegun